CGRCX
Price
$31.46
Change
+$0.13 (+0.41%)
Updated
Jul 10 closing price
Net Assets
836.67M
RMEBX
Price
$64.23
Change
-$0.20 (-0.31%)
Updated
Jul 13 closing price
Net Assets
118.05B
Interact to see
Advertisement

CGRCX vs RMEBX

CGRCX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
CGRCX vs. RMEBX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGRCX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. CGRCX (837M). RMEBX pays higher dividends than CGRCX: RMEBX (1.00) vs CGRCX (0.65). CGRCX was incepted earlier than RMEBX: CGRCX (30 years) vs RMEBX (12 years). CGRCX (1.68) is less costly to investors than RMEBX (1.07). CGRCX is a more actively managed with annual turnover of: 67.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than CGRCX: RMEBX (250) vs CGRCX (1000). RMEBX annual gain was more profitable for investors over the last year : 8.73 vs. CGRCX (4.01). RMEBX return over 5 years is better than : 36.28 vs. CGRCX (2.90).
CGRCXRMEBXCGRCX / RMEBX
Total Expense Ratio1.681.07157%
Annual Report Gross Expense Ratio1.681.07157%
Fund Existence30 years12 years-
Gain YTD8.5179.05994%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets837M118B1%
Annual Yield % from dividends0.651.0065%
Returns for 1 year4.018.7346%
Returns for 3 years6.8534.3020%
Returns for 5 years2.9036.288%
Returns for 10 years12.6789.3614%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FASGX33.61N/A
N/A
Fidelity Asset Manager 70%
FBTIX51.28N/A
N/A
Fidelity Advisor Biotechnology I
FLUAX30.95N/A
N/A
Fidelity Advisor Stk Selec Lg Cp Val A
MUHLX79.09N/A
N/A
Muhlenkamp
AXVIX21.80N/A
N/A
Acclivity Small Cap Value I